Smita Mascharak

Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy

H. Okada, M. Aghi, G. Yagnik, 2017, Oncogene.

Do surgical emergencies stay at home? Observations from the first United States Coronavirus epicenter

E. Lewis, M. Stone, J. McNelis, 2021, The journal of trauma and acute care surgery.

Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer

A. Sali, Catherine C. Park, D. Schneidman-Duhovny, 2017, Proceedings of the National Academy of Sciences.

GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.

A. Molinaro, P. Eriksson, S. Ronen, 2017, JCI insight.

Dexamethasone-mediated changes in adipose triacylglycerol metabolism are exaggerated, not diminished, in the absence of a functional GR dimerization domain.

Cyrus F. Khambatta, M. Hellerstein, C. Harris, 2013, Endocrinology.

Contribution of Adipose-Derived Factor D/Adipsin to Complement Alternative Pathway Activation: Lessons from Lipodystrophy

Charles A. Harris, D. Hourcade, J. Atkinson, 2018, The Journal of Immunology.

Panel composition and disparities in the topics of presentation in vascular surgery conferences.

I. Koleilat, E. Lipsitz, K. Choinski, 2023, Vascular.